https://www.jst.go.jp/pr/announce/20221017/pdf/20221017.pdf Kosuke Sato and colleagues have embedded “edible information” into cookies using a 3D printer. 2D codes, or AR markers, are created through cavities when the food is printed and remain intact during baking. They can be read again when the back of the cookies are exposed to high-frequency light, and not only store data […]
Blick nach Asien 2022/12
Blick nach Asien 2022:12
Nagase and Hitachi collaborate for commercialization of ergothioneine
https://bio.nikkeibp.co.jp/atcl/news/p1/22/11/04/10118/ Ergothioneine has antioxidant activity and is believed to improve brain function, thus of interest for applications in functional foods, cosmetics, and pharmaceuticals. Ergothioneine is produced only in very small amounts by mushrooms and microorganisms. In the joint project, Nagase produces ergothioneine from highly genetically modified Escherichia coli. Hitachi Plant Services uses computing and machine learning to […]
Microwave Chemical Co. completes 1 t/d demonstration facility for microwave-based recycling of plastics
https://www.nedo.go.jp/news/press/AA5_101587.html Under a contract from NEDO, Microwave Chemical Co. has completed Japan’s first general-purpose microwave demonstration facility for the recovery of monomers from polymers with a processing capacity of 1 ton per day. In 2021, the company had completed a small-scale demonstration facility with a processing capacity of about 5 kg per hour. The process will be further scaled […]
NEDO initiates program on blue ammonia production
https://www.nedo.go.jp/news/press/AA5_101590.html According to Japan’s “Sixth Basic Energy Plan” of October 2021 hydrogen and ammonia power generation is expected to account for about 1% of Japan’s power mix in FY2030. Following this target, NEDO and INPEX Corp. will construct a “blue ammonia” facility at the INPEX Higashi-Kashiwazaki gas field in Kashiwazaki City, Niigata Prefecture. A demonstration […]
METI secures 2 billion € fund to promote biomanufacturing (bio monozukuri)
https://bio.nikkeibp.co.jp/atcl/news/p1/22/11/08/10133/ METI will allocate 300 billion yen (2 billion €) to a new fund that will support companies that develop manufacturing technologies using bioprocesses based on waste and other raw materials. Specifically, it is envisioned that microorganisms will be used to produce fiber, ethanol, resins, and other products from waste clothing, municipal solid waste, food […]
Osaka University team prints edible QR code into cookies
https://www.jst.go.jp/pr/announce/20221017/pdf/20221017.pdf Kosuke Sato and colleagues have embedded “edible information” into cookies using a 3D printer. 2D codes, or AR markers, are created through cavities when the food is printed and remain intact during baking. They can be read again when the back of the cookies are exposed to high-frequency light, and not only store data […]
High yields of biologics from an “egg factory”
The team of Isao Oishi at the National Institute of Advanced Industrial Science and Technology (AIST) in Osaka has developed an “egg factory” which produces up to 500 mg of recombinant proteins such as human interferon beta, cytokines, and a human HER2 antibody per chicken egg. The method is based on knocking in the target gene […]
2022/10 Cyfuse reports progress on 3D printed organoids
https://bio.nikkeibp.co.jp/atcl/news/p1/22/10/27/10073/ https://en.cyfusebio.com Cyfuse was established in 2010 and is focused on 3D cell technology that uses a bio 3D printer to laminate cell clumps (spheroids) consisting of an average of 10,000 cells in a 3D manner without the use of artificial scaffolds. The company has 3 business fields: to develop a pipeline of regenerative medicine […]
Cyfuse raises about 13 million € for 3D printed organoids
https://bio.nikkeibp.co.jp/atcl/news/p1/22/10/27/10073/ https://en.cyfusebio.com Cyfuse was established in 2010 and is focused on 3D cell technology that uses a bio 3D printer to laminate cell clumps (spheroids) consisting of an average of 10,000 cells in a 3D manner without the use of artificial scaffolds. The company has 3 business fields: to develop a pipeline of regenerative medicine […]